Healthcare Regulation (HIPAA)

As security leaders prepare for the Gartner Summit, a new analyst watch list offers a roadmap to the AI-driven vendors and trends shaping the industry's bottom line.

A record verdict in a retaining wall collapse reveals more than a local tragedy; it exposes a systemic breakdown in safety, regulation, and corporate risk.

ADC Therapeutics' lymphoma drug ZYNLONTA shows promise in a Phase 3 trial, but a concerning safety signal in older patients complicates its path to market.

Fairplay's new user verification signals a market-wide shift. As India's stringent new rules take hold, compliance is becoming a key strategic asset.

A new partnership with Scala.AI aims to move beyond simple telehealth, using deep operational intelligence to fix healthcare's costly fragmentation and poor navigation.

Physicians are being warned about indemnification clauses in contracts that can shift immense liability. Here's what doctors need to know to avoid financial ruin.

Eyebot and The Framery's new partnership offers 15-minute prescriptions via mall kiosks, blending tech and retail. But can this model truly disrupt the optical industry?

The market for T-cell malignancy treatments is set to surpass $1.8B, fueled by a pipeline of innovative drugs aiming to meet vast unmet patient needs.

The strategic acquisition of veteran attorney Mark Tabakin and his six-person team signals a major escalation in Scarinci Hollenbeck's statewide ambitions.

EZContacts' new 'top retailer' award highlights the online eyewear boom. But the real story is the underlying system reshaping a regulated, high-friction industry.

As corporate interests reshape medicine, a leading physician's call for stewardship revives a debate on the soul of healthcare. Can timeless values survive?

New data on Syndax Pharma's Revuforj shows a 90% survival rate in a high-risk leukemia group, signaling a potential paradigm shift and major market catalyst.

A new report shows California's self-insured employers face a puzzling trend: workers' comp claims are at a 5-year low, yet costs are surging. Why?

With CE Mark approval for its SOUND REACH Swift, Genesis MedTech brings a 'plug-and-play' ultrasonic shear to Europe, promising to simplify complex open surgeries.

Provincial governments are using a constitutional override to end labour disputes, sparking a national outcry. Is this a savvy tactic or an erosion of rights?

Intended to heal, some Physician Health Programs are accused of using flawed science and financial coercion to ruin careers. Are they a safety net or a trap?

As Capital Edge marks 16 years by reaffirming its niche focus, we explore the explosive growth of specialized consulting driven by byzantine federal rules.

A call for research on vaccine side effects exposes a deeper crisis: the collapse of public trust in science. Can rigorous data heal a polarized nation?

A pivotal partnership between WeInfuse and Trial IQ leverages AI to bring clinical trials to local infusion centers, signaling a major shift in drug development.

Cell therapies promise miracles, but a decades-old test for cell health is flawed. A new global standard aims to bring much-needed precision and safety.